查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2153349

全球糖尿病視網膜病變市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Diabetic Retinopathy Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 170 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球糖尿病視網膜病變市場預計將從2025年的62.2億美元成長至2034年的201.9億美元，2026年至2034年的複合年成長率（CAGR）為13.97%。全球糖尿病視網膜病變市場正因糖尿病在全球日益嚴重的負擔而顯著擴張。隨著糖尿病患者人數的增加，視力相關併發症的風險也隨之上升，推動了對有效診斷和治療方案的需求。早期篩檢計畫的進行和影像技術的進步提高了檢出率，也為市場成長提供了支撐。

關鍵成長要素包括抗血管內皮生長因子（VEGF）療法、雷射治療和外科手術的進步。人們對定期眼科檢查的認知不斷提高，以及政府為促進糖尿病管理而採取的舉措，進一步推動了市場擴張。此外，人工智慧（AI）在視網膜成像領域的應用，也提高了診斷的準確性和效率。

展望未來，生物製藥和長效療法的持續創新預計將對市場產生積極影響。遠距眼科服務和數位健康平台有望擴大眼科醫療服務的覆蓋範圍，尤其是在農村地區。隨著醫療系統將重點放在預防糖尿病相關併發症上，預計未來幾年對糖尿病視網膜病變治療的需求將穩定成長。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節對市場進行了清晰的說明，包括關鍵定義、分類以及當前行業格局的概述。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分根據產品類型、應用、最終用戶和地區將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業進行了詳細評估，包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭趨勢和主要參與者所採取的策略。

市場預測：本部分提供基於數據的市場規模和成長模式預測，預測期為特定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析，以識別未來預期趨勢。

區域分析：這包括對主要地理區域的市場表現進行全面檢驗，確定高成長地區和區域趨勢，以更深入地了解區域市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的報告客製化服務，以滿足您的特定需求。這包括額外的細分、國家/地區分析、競爭對手分析、客製化資料點或針對特定細分市場的洞察，以更好地支援您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球糖尿病視網膜病變市場：依類型分類

  • 市場分析、洞察與預測
  • 增殖性糖尿病視網膜病變
  • 糖尿病黃斑部水腫（DME）

第5章 全球糖尿病視網膜病變市場：依治療類型分類

  • 市場分析、洞察與預測
  • 抗 VEGF 藥物
  • 類固醇植入
  • 雷射手術
  • 玻璃體切除手術

第6章 全球糖尿病視網膜病變市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 中國
    • 日本
    • 韓國
    • 印度
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第7章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第8章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Regeneron Pharmaceuticals
    • Roche
    • Bayer
    • Novartis
    • AbbVie
    • Alimera Sciences
    • Genentech
    • Apellis Pharmaceuticals
    • Oxurion
    • Kodiak Sciences
    • EyePoint Pharmaceuticals
    • Santen Pharmaceutical
    • Ocular Therapeutix
    • Clearside Biomedical
    • REGENXBIO
    • Adverum Biotechnologies
    • 4D Molecular Therapeutics
    • Opthea
    • Janssen
    • Eli Lilly
簡介目錄
Product Code: VMR112113274

The global diabetic retinopathy market size is expected to reach USD 20.19 Billion in 2034 from USD 6.22 Billion in 2025, growing at a CAGR of 13.97% during 2026-2034.The global diabetic retinopathy market is expanding significantly due to the rising global burden of diabetes. As the number of diabetic patients increases, the risk of vision-related complications is also growing, driving demand for effective diagnostic and treatment solutions. Early screening programs and improved imaging technologies have enhanced detection rates, supporting market growth.

Major drivers include advancements in anti-VEGF therapies, laser treatments, and surgical interventions. Increasing awareness about regular eye examinations and government initiatives promoting diabetes management are further strengthening market expansion. The integration of artificial intelligence in retinal imaging is also improving diagnostic accuracy and efficiency.

Looking forward, the market is expected to benefit from continued innovation in biologic therapies and long-acting treatment options. Teleophthalmology services and digital health platforms may expand access to eye care, particularly in rural areas. As healthcare systems focus on preventing diabetes-related complications, the demand for diabetic retinopathy treatments is projected to grow steadily in the coming years.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Type

  • Proliferative Diabetic Retinopathy
  • Diabetic Macular Edema (DME)

By Treatment Type

  • Anti VEGF Drug
  • Steroid Implants
  • Laser Surgeries
  • Vitrectomy

COMPANIES PROFILED

  • Regeneron Pharmaceuticals, Roche, Bayer, Novartis, AbbVie, Alimera Sciences, Genentech, Apellis Pharmaceuticals, Oxurion, Kodiak Sciences, EyePoint Pharmaceuticals, Santen Pharmaceutical, Ocular Therapeutix, Clearside Biomedical, REGENXBIO, Adverum Biotechnologies, 4D Molecular Therapeutics, Opthea, Janssen, Eli Lilly

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL DIABETIC RETINOPATHY MARKET: BY TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Type
  • 4.2. Proliferative Diabetic Retinopathy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Diabetic Macular Edema (DME) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL DIABETIC RETINOPATHY MARKET: BY TREATMENT TYPE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Treatment Type
  • 5.2. Anti VEGF Drug Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Steroid Implants Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Laser Surgeries Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Vitrectomy Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL DIABETIC RETINOPATHY MARKET: BY REGION 2022-2034 (USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Type
    • 6.2.2 By Treatment Type
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Type
    • 6.3.2 By Treatment Type
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Spain
    • 6.3.8 Russia
    • 6.3.9 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Type
    • 6.4.2 By Treatment Type
    • 6.4.3 China
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 India
    • 6.4.7 Australia
    • 6.4.8 South East Asia
    • 6.4.9 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Type
    • 6.5.2 By Treatment Type
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Type
    • 6.6.2 By Treatment Type
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL DIABETIC RETINOPATHY INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 Regeneron Pharmaceuticals
    • 8.2.2 Roche
    • 8.2.3 Bayer
    • 8.2.4 Novartis
    • 8.2.5 AbbVie
    • 8.2.6 Alimera Sciences
    • 8.2.7 Genentech
    • 8.2.8 Apellis Pharmaceuticals
    • 8.2.9 Oxurion
    • 8.2.10 Kodiak Sciences
    • 8.2.11 EyePoint Pharmaceuticals
    • 8.2.12 Santen Pharmaceutical
    • 8.2.13 Ocular Therapeutix
    • 8.2.14 Clearside Biomedical
    • 8.2.15 REGENXBIO
    • 8.2.16 Adverum Biotechnologies
    • 8.2.17 4D Molecular Therapeutics
    • 8.2.18 Opthea
    • 8.2.19 Janssen
    • 8.2.20 Eli Lilly